Nicotine Replacement Therapy Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Systematic review and meta-analysis investigating nicotine, cotinine, and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy
CONCLUSION: People who smoke but who also use NRT reported smoking less heavily than when solely smoking, and when NRT was used as 'preloading' this reported smoking reduction was biochemically confirmed. There was no evidence concurrent smoking and NRT use resulted in greater nicotine exposure than smoking.PMID:37479301 | DOI:10.3399/bjgp23X734241 (Source: The British Journal of General Practice)
Source: The British Journal of General Practice - July 21, 2023 Category: Primary Care Authors: Anna Podlasek Ravinder Claire Katarzyna A Campbell Sophie Orton Ross Thomson Tim Coleman Source Type: research

Exploring the ChatGPT platform with scenario-specific prompts for vaping cessation
CONCLUSION: If managed by a group of experts, including clinicians, and behavioral and computer scientists, a platform such as the ChatGPT may be leveraged to design tailored interventions for tobacco use cessation, including vaping cessation.PMID:37460216 | DOI:10.1136/tc-2023-058009 (Source: Cancer Control)
Source: Cancer Control - July 17, 2023 Category: Cancer & Oncology Authors: Samia Amin Crissy Terawaki Kawamoto Pallav Pokhrel Source Type: research

Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression
Conclusions Our findings indicate that both smoking and passive smoking have a negative influence on MS and that smoking cessation post diagnosis may be an important secondary preventive measure. Snuff use was associated with slower disease progression, suggesting that nicotine replacement therapy could be an attractive way to increase the chance of quitting smoking among patients with MS. (Source: Journal of Neurology, Neurosurgery and Psychiatry)
Source: Journal of Neurology, Neurosurgery and Psychiatry - July 13, 2023 Category: Neurosurgery Authors: Wu, J., Olsson, T., Hillert, J., Alfredsson, L., Hedström, A. K. Tags: JNNP Patients' choice, Open access Multiple sclerosis Source Type: research

Cytisinicline to Speed Smoking Cessation in the United States
In 1984, the US Food and Drug Administration (FDA) approved nicotine gum as the first pharmacotherapy for cigarette smoking cessation. Other types of nicotine replacement therapy have followed (nicotine lozenges, transdermal patches, inhaler, and a nasal spray), and in 1997, the first non-nicotine pharmacotherapy, bupriopion, was approved. The FDA has not approved a new drug with an indication for smoking cessation since varenicline was approved in 2006. For over a decade, more than 50% of US adults who smoke have attempted to quit at least once each year, with around 7% of those who smoke achieving abstinence each year fo...
Source: JAMA - July 11, 2023 Category: General Medicine Source Type: research

Evaluation of a Pharmacist-Linked Smoking Cessation Intervention for Adults Experiencing Homelessness
Conclusions: A pharmacist-linked smoking cessation program at transitional homeless shelters can reduce structural barriers to cessation care and reduce tobacco use among people experiencing homelessness.PMID:37401115 | DOI:10.1080/10826084.2023.2231060 (Source: Substance Use and Misuse)
Source: Substance Use and Misuse - July 4, 2023 Category: Addiction Authors: Gea De Los Reyes Amena Ng Jazmin Valencia Chavez Dorie E Apollonio Lisa Kroon Phoebe Lee Maya Vijayaraghavan Source Type: research

Enhancing long-term smoking abstinence among individuals with a history of cervical intraepithelial neoplasia or cervical cancer (Project ACCESS): protocol for a randomized clinical trial
This study builds on promising results from our recent trial which found that MAPS was associated with substantially higher abstinence from smoking at the end of the 12-month treatment period. Finding that this low-burden, personally tailored digital treatment adjuvant improves the long-term efficacy of MAPS would have important clinical and public health implications.TRIAL REGISTRATION: Clinical Trials Registry NCT05645146; https://clinicaltrials.gov/ct2/show/NCT05645146 ; Registered on December 9, 2022.PMID:37403057 | DOI:10.1186/s12889-023-16189-3 (Source: Cancer Control)
Source: Cancer Control - July 4, 2023 Category: Cancer & Oncology Authors: Jennifer I Vidrine Bethany Shorey Fennell Vani N Simmons Steven K Sutton Sarah R Jones Honor W Woodward Charles E Hoogland Damon J Vidrine Source Type: research

Management of nicotine dependence in patients with psychiatric disorders - recommendations of the Polish Psychiatric Association - part II
Psychiatr Pol. 2023 May 5:1-13. doi: 10.12740/PP/OnlineFirst/161774. Online ahead of print.ABSTRACTThe development of treatment methods for nicotine dependence has progressed slowly because people with psychiatric disorders are usually excluded from participating in clinical trials. There are several therapeutic options to support smoking cessation, including psychological and pharmacological interventions, which should be offered to smokers with mental disorders. The first step in helping tobacco smokers and nicotine-dependent individuals is the assessment of smoking intensity and confirmation of nicotine dependence. Curr...
Source: Psychiatria Polska - June 28, 2023 Category: Psychiatry Authors: Marcin Wojnar Piotr Wierzbi ński Jerzy Samochowiec Joanna Rymaszewska Krzysztof J Filipiak Adam Wichniak Robert Mr óz Artur Mamcarz Dominika Dudek Source Type: research